Journal article
Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial
Abstract
BACKGROUND: The CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) trial was a multicenter randomized controlled trial assessing convalescent plasma in hospitalized COVID-19 patients. This study evaluates the cost-effectiveness of convalescent plasma and its impact on quality-of-life to provide insight into its potential as an alternative treatment in resource-constrained settings.
METHODS: Individual …
Authors
Tse P; Yan J; Liu Y; Jamula E; Heddle N; Bazin R; Robitaille N; Cook R; Turgeon A; Fergusson D
Journal
Transfusion, Vol. 64, No. 4, pp. 606–614
Publisher
Wiley
Publication Date
April 2024
DOI
10.1111/trf.17777
ISSN
0041-1132